| Literature DB >> 26633357 |
Xiaoxu Yang1, Feng Yan2, Zhicheng He3, Shan Liu4, Yeqing Cheng5, Ke Wei6, Shiquan Gan7, Jing Yuan8, Shang Wang9, Ye Xiao10, Kaiqun Ren11, Ning Liu12, Xiang Hu13, Xiaofeng Ding14, Xingwang Hu15,16, Shuanglin Xiang17.
Abstract
Intersectin-2Long (ITSN2L) is a multi-domain protein participating in endocytosis and exocytosis. In this study, RABEP1 was identified as a novel ITSN2L interacting protein using a yeast two-hybrid screen from a human brain cDNA library and this interaction, specifically involving the ITSN2L CC domain and RABEP1 CC3 regions, was further confirmed by in vitro GST (glutathione-S-transferase) pull-down and in vivo co-immunoprecipitation assays. Corroboratively, we observed that these two proteins co-localize in the cytoplasm of mammalian cells. Furthermore, over-expression of ITSN2L promotes RABEP1 degradation and represses RABEP1-enhanced endosome aggregation, indicating that ITSN2L acts as a negative regulator of RABEP1. Finally, we showed that ITSN2L and RABEP1 play opposite roles in regulating endocytosis. Taken together, our results indicate that ITSN2L interacts with RABEP1 and stimulates its degradation in regulation of endocytosis.Entities:
Keywords: ITSN2L; RABEP1; endocytosis; endosome; interactions
Mesh:
Substances:
Year: 2015 PMID: 26633357 PMCID: PMC4691038 DOI: 10.3390/ijms161226091
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Identification of Intersectin-2Long-coiled-coil (ITSN2L-CC) domain-interacting partners by Y2H screen and verification of interaction between ITSN2L and rabaptin-5 (RABEP1) in vitro. (A) Schematic representation of the domain structure of ITSN2L and RABEP1 used in this study; (B) The colonies were grown on SC-Leu-Trp-His+30 mM AT plates after transformation with pDBLeu-ITSN2L-CC and pPC86-human brain cDNA library and then duplicated onto a nylon membrane for the Beta-Gal assay. Positive clones were confirmed by retransformation and sequences were further analyzed; (C) Purified GST-RABEP1 fusion detected by anti-GST antibody; (D) Purified His-ITSN2L fusion detected by anti-His antibody; (E) GST pull-down assays analyzing interaction between these subdomains of ITSN2L and RABEP1. Proteins pulled down were detected by anti-His antibody.
Figure 2Co-immunoprecipitation of ITSN2L and RABEP1. (A) Rabbit ITSN2L recognize both human ITSN2 long and short isoforms; (B) HeLa cells were transfected with Myc-RABEP1 or Myc-ITSN2L, respectively, and cell lysates were subjected to immunoprecipitation using rabbit polyclonal anti-Myc or rabbit preimmune IgG. The IP materials were analyzed with anti-ITSN2L (upper panel) or anti-RABEP1 (lower panel), respectively; (C) Lysates from HeLa cells were subjected to IP using mouse monoclonal anti-RABEP1 or rabbit pre-immune IgG and immunoblotted with rabbit polyclonal anti-ITSN2L (upper panel), or IP using rabbit polyclonal anti-ITSN2L or rabbit preimmune IgG and immunoblotted with mouse monoclonal anti-RABEP1 (lower panel).
Figure 3Co-localization of ITSN2L and RABEP1 in HeLa cells. Upper panels show localization of endogenous ITSN2L and RABEP1, ITSN2L was detected by rabbit polyclonal anti-ITSN2L antibody and Alexa-488 goat anti-rabbit secondary antibody, and RABEP1 by mouse monoclonal anti-RABEP1 antibody and Alexa-594 goat anti-mouse secondary antibody; Lower panels show localization of GFP-ITSN2L and Myc-RABEP1, detected with mouse monoclonal anti-Myc antibody and Alexa-594 conjugated goat anti-mouse secondary antibody.
Figure 4ITSN2L inhibits the accumulation of vesicles induced by Myc-RABEP1 and promotes RABEP1 degradation. (A) HeLa cells transfected with Myc-RABEP1show the accumulation of large vesicles, while Myc-RABEP1co-transfected with GFP-ITSN2L revealed reduced large vesicles. The images were taken at a magnification of 600; (B) Expression of endogenous RABEP1 was reduced when cells over expressing ITSN2L HeLa cells were transfected with GFP or GFP-ITSN2L, cell lysates were detected with anti-GFP, anti-RABEP1 and anti-GAPDH antibodies; (C) The induced degradation can be rescued by proteasome inhibitors. HeLa cells pre-treated with NH4Cl (10 mM), MG132 (20 μM), lactacystin (20 μM), and chloroquine (100 μM) were then transfected with GFP-ITSN2L with inhibitors present throughout; (D) Half-life of RABEP1 protein after ITSN2L Overexpression. HeLa cells transfected with GFP-ITSN2L or GFP were incubated with cycloheximide and time points were taken. Cells of each sample were then lysed and detected by the indicated antibodies; (E) Ubiquitination of RABEP1 upon ITSN2L overexpressed. HeLa cells transfected with indicated amount of GFP-ITSN2L were lysed and the same amount of total protein used for immunoprecipitation of RABEP1 and detected by the indicated antibodies.
Figure 5ITSN2L knockdown induce up-regulation of RABEP1. (A) HeLa cells transfected with siRNA-A, B, C and control respectively. Cell lysates were detected by western blotting with anti-ITSN2L and anti-β-actin antibody; (B) HeLa cells transfected with siRNA-A and control, subsequently stained with anti-ITSN2L and anti-RABEP1 antibody. Photos of si-RNA and control samples were taken under the same conditions of exposure; (C) HeLa cells transfected with siRNA-A and control. Cell lysates were detected by anti-ITSN2L, anti-RABEP1 and anti-GAPDH antibodies.
Figure 6ITSN2L and RABEP1 play opposite roles in Transferrin uptake. (A) HeLa cells were transfected with GFP-ITSN2L or Myc-RABEP1. Overexpression of GFP-ITSN2L inhibited Tf uptake, while Myc-RABEP1 enhanced Tf uptake. Representative cells were marked by yellow arrows; (B) Knock down ITSN2L using si-RNA enhances the uptake of Tf; (C) Reduced RABEP1 expression caused a strong inhibition of Tf internalization. Pictures of si-RNA and control were acquired under the same exposure conditions; (D) Tf uptake signals of each group were measured with integral densities of red channel by imageJ and statistical analysis were carried out by t-test (*** p < 0.001, ** p < 0.01, * p < 0.05).